EUVIMEDEUVIMED entdecken
Crossref

Impact of Pre-Injury Selective Serotonin Reuptake Inhibitor Use on Neurological Outcomes and Physical Disability in Hospitalized Traumatic Brain Injury Patients: Single-Center Retrospective Study

Oluwakemi Rasheedat Mogaji iD, Pranav Singh, Joshua Randles, Ryan McMahon, Brittany Hout, Heather Wallace iD, James Aden, Julie Rizzo

Military Medicine · 04.11.2026

DOI: 10.1093/milmed/usag506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, online erschienen am 04.11.2026. Verfasst von Oluwakemi Rasheedat Mogaji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Surgery Critical Care Physician Assistant Program, Brooke Army Medical Center, Fort Sam Houston, TX 78234, United States. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Selective serotonin reuptake inhibitors (SSRIs) are a first-line treatment for various psychiatric disorders, yet established evidence demonstrates their role in increasing bleeding risk. Given the significant public health burden of traumatic brain injury (TBI) and the high prevalence of SSRI use among the general population, investigating how pre-injury exposure influences hemorrhagic TBI outcomes is essential to inform clinical practice. This study explores this intersection to identify potential risks to neurological and functional recovery. Materials and Methods We conducted a single-center retrospective study of trauma patients admitted to a level 1 trauma center for hemorrhagic TBI between 2016 and 2021. The Institutional Review Board (IRB) determined this study to be exempt from formal review. We conducted 2:1 propensity score matching based on age, sex, and BMI to establish an SSRI-use group (n = 96) and a control group (n = 128). Primary outcomes included neurological status (GCS) and functional status (AM-PAC) at hospital discharge. We employed multivariable linear regression to assess the independent association between pre-injury SSRI use and discharge outcomes while adjusting for age, sex, and BMI.

Results

Unadjusted analysis revealed that SSRI users had significantly lower GCS scores at admission (P = .05) and discharge (P = .02). However, after adjusting for covariates, pre-injury SSRI use was not an independent predictor of discharge GCS (β = −0.0957, P = .38). Conversely, SSRI use was independently associated with significantly lower AM-PAC scores at discharge (β = −1.22, P = .01). Furthermore, SSRI users were significantly more likely to require discharge to a Skilled Nursing Facility (60.98% vs. 39.02%, P = .02). No significant differences were observed in hospital length of stay (P = .08).

Conclusions

Pre-injury SSRI use was not an independent predictor of neurological status (GCS) recovery at discharge. However, it was independently associated with worse physical disability (AM-PAC) and a significantly higher likelihood of requiring post-acute rehabilitation (SNF discharge). These findings suggest that pre-injury SSRI use could influence the clinical trajectory and functional recovery of TBI patients. Clinicians should consider pre-injury SSRI use a risk factor that may inform the need for specialized post-acute care.

Autor:innen und Institutionen

  • Surgery Critical Care Physician Assistant Program, Brooke Army Medical Center, Fort Sam Houston, TX 78234, United States.
  • The Robbins College of Health and Human Sciences, Baylor University, Waco, TX 76706, United States.
  • Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, MD 20814, United States.
  • Statistics Program, Brooke Army Medical Center, Fort Sam Houston, TX 78234, United States.

ORCID-Profile: Oluwakemi Rasheedat Mogaji, Heather Wallace

Zitieren

APA

Mogaji, O. R., Singh, P., Randles, J., McMahon, R., Hout, B., Wallace, H., Aden, J., & Rizzo, J. (2026). Impact of Pre-Injury Selective Serotonin Reuptake Inhibitor Use on Neurological Outcomes and Physical Disability in Hospitalized Traumatic Brain Injury Patients: Single-Center Retrospective Study. Military Medicine. https://doi.org/10.1093/milmed/usag506

Vancouver

Mogaji OR, Singh P, Randles J, McMahon R, Hout B, Wallace H, et al. Impact of Pre-Injury Selective Serotonin Reuptake Inhibitor Use on Neurological Outcomes and Physical Disability in Hospitalized Traumatic Brain Injury Patients: Single-Center Retrospective Study. Military Medicine. 2026. doi:10.1093/milmed/usag506

BibTeX
@article{Mogaji2026,
  author = {Mogaji, Oluwakemi Rasheedat and Singh, Pranav and Randles, Joshua and McMahon, Ryan and Hout, Brittany and Wallace, Heather and Aden, James and Rizzo, Julie},
  title = {Impact of Pre-Injury Selective Serotonin Reuptake Inhibitor Use on Neurological Outcomes and Physical Disability in Hospitalized Traumatic Brain Injury Patients: Single-Center Retrospective Study},
  journal = {Military Medicine},
  year = {2026},
  doi = {10.1093/milmed/usag506}
}
Kostenlos starten →